I am concerned about the drug pricing protocols in the Build Back Better Act, and they would have the opposite effect limiting research and hampering innovation, in my view.
Editor's note · Context
Bucshon criticizes the drug pricing measures in the Build Back Better Act for hindering innovation.
Share
More from Larry Bucshon
I want to reiterate, as a physician, I believe the vaccines are safe and effective, and I would hope that people can make the personal choice to get vaccinated. It should be just that, their personal choice, not the choice of the Federal…
This amendment will provide clarity that research conducted by the Department of Defense is included in the research registration process outlined in the bill. It also requires the Office of the Inspector General at the Department of…
I am glad we are here today. I was a healthcare provider before I was in the Congress for 15 years, and I find when you have legislation like this that comes up, it is surprising that we have to, literally, as they say, have an act of…
In closing, I encourage a ``yes'' vote on this bill, and I yield back the balance of my time. The SPEAKER pro tempore (Mr. Valadao). The question is on the motion offered by the gentleman from Indiana (Mr. Bucshon) that the House suspend…





